drugset / Trial / NCT02286999

Probiotic Supplementation in Breastfed Newborn Infants

NCT02286999

Phase 1 Withdrawn Emanual Maverakis, MD
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to investigate the dose of a probiotic supplement (Bifidobacterium longum subsp. infantis) required to achieve predominant gut colonization in healthy newborn, breastfed infants. The study will also examine whether supplementation with this probiotic can reduce the chance of developing eczema and food allergies in enrolled infants.

Timeline

Start
2015-10
Primary completion
2018-01
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject VSL#3 Other / unclassified